Bruker unveils various new instruments, software at Analytica 2022
Bruker launched various scientific instruments, software, and other products at Analytica 2022, which took place June 21-24 in Munich. Read More
Limiting gene interactions can prevent melanoma
When it comes to melanoma, a new study published this month in the journal Nature Communications found that limiting interactions of the genes NRAS-BRAF could prevent the formation of the NRAS mutant that causes melanoma. Read More
Berkeley Lights highlights research, products at ESCAT 2022
Berkeley Lights is participating in the 27th Annual European Society for Animal Cell Technology (ESCAT), June 26-29 in Lisbon, in symposium sessions and by showcasing its products at a vendor booth. Read More
Illumina, Merck develop new oncology assay
Illumina codeveloped a research test with Merck that assesses a new genomic signature with its TruSight Oncology 500 assay. Read More
Labcorp partners with HealthVerity on real-world data
Labcorp is partnering with HealthVerity, an identity, privacy, governance, and exchange company, to access fully interoperable, HIPAA-compliant real-world data from the U.S.’s largest ecosystem of healthcare and consumer data. Read More
Florence Healthcare closes $27M series C funding round
Clinical trial software company Florence Healthcare has completed its $27 million series C funding round, led by global software investor Insight Partners. Read More
Aizon unveils new data processing product
Aizon debuted its new good practice-compliant data processing product, Aizon Digitize, which supports life sciences manufacturers with digitization, productivity, and avoiding time-consuming data inputs. Read More
PerkinElmer debuts new automated GC-MS product
PerkinElmer launched its GC 2400 platform, an automated gas chromatography (GC) headspace sampler and GC-mass spectrometry (GC-MS) product. Read More
Researchers identify how bacterium that causes tuberculosis evolves rapidly
A new study has identified how the bacterium that causes tuberculosis can evolve rapidly in response to new environments, providing insights into how Mycobacterium tuberculosis grows to resist antibiotics with the potential for developing more effective treatments. Read More
Plant virus, antibody activates immune system's 'natural killer' cells
University of California, San Diego researchers have shown in a study that a new combination therapy to combat cancer may one day consist of a plant virus and antibody that activates the immune system's “natural killer” cells. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
